|
Includes all of these presentations from this session:
| # |
Presentation |
Speaker |
| 1 |
When does Barretts go from dysplasia to early cancer? |
M. Lisovsky (Lebanon) |
| 2 |
What is the role of Nissen fundoplication after Barrett's ablation? |
A. Badaloni (Buenos Aires) |
| 3 |
Will confocal microscopy or high definition EUS be the future diagnostic tool for very early esophageal cancers? |
T.D. Wang (Rochester, MN) |
| 4 |
Is CT or PET/CT worthwhile ordering for early cancers? |
P. Pokieser (Vienna) |
| 5 |
Tubular widespread ESD in the esophagus with high dose steroid stricture prevention |
J. Hochberger (Strasbourg) |
| 6 |
Is ablation the best method of treating early esophageal cancers? |
H. Inoue (Yokohama) |
| 7 |
What is the optimal follow-up schedule after ablation of HGD/intramucosal cancers? |
H. Udagawa (Tokyo) |
| 8 |
What role might NOTES play in early esophageal cancer? |
K. Nason (Pittsburgh) |
| 9 |
China?s national early detection and early treatment program |
Guiqi Wang (Beijing) |
|
